Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN109574938B reveals a novel synthesis route for Rosuvastatin Sodium featuring mild conditions, high atom economy, and superior stereoselectivity for industrial scale-up.
Patent CN105111136B reveals a novel synthesis route for piperidine ketones offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN113980017A reveals a high-yield asymmetric hydrogenation route for tetrahydro-13-methyl berberine derivatives, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Novel copper-catalyzed route for pyrone[3,4-b]indole derivatives. Reduces cost, simplifies scale-up for pharma intermediates.
Advanced synthesis method for high-purity deuterated celecoxib intermediate offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel synthesis method for NR chloride using TMSOTf activation. Reduces cost and improves purity for pharmaceutical intermediates manufacturing.
Patent CN101941971B details a green synthesis of Evodiamine via catalytic hydrogenation and anhydride condensation, offering high purity and cost reduction for pharma manufacturing.
Patent CN106220586A details a metal-free synthesis of 5-amino-1,2,4-selenadiazole derivatives using selenium powder, offering high yields and supply chain reliability for pharmaceutical intermediates.
Patent CN106467481A enables green synthesis of indole-3-aryl ketones. Visible light catalysis reduces costs and ensures reliable pharmaceutical intermediates supplier continuity.
Novel Pd-catalyzed method offers high yield and enantioselectivity for chiral intermediates. Reduces costs and simplifies supply chain for pharmaceutical manufacturing partners globally.
Novel Grignard route for Lasmiditan precursors offering high yield and reduced waste for reliable API manufacturing supply chains.
Advanced refining patent CN115594643B ensures high purity triazole intermediates. Significant cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Novel patent CN107382897A enables high-purity Betrixaban intermediate production with reduced waste and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN103189352A reveals a novel organocatalytic Mannich reaction for high-purity pharmaceutical intermediates, offering significant cost reduction and scalable supply chain solutions.
Discover a novel Brivaracetam synthesis method avoiding chiral columns. Enhanced purity, reduced costs, and scalable manufacturing for pharmaceutical intermediates.
Patent CN104513117B details copper-catalyzed asymmetric decarboxylation for high-purity intermediates. Offers cost reduction and scalable supply chain solutions for global pharma manufacturing.
Patent CN102532225A details a novel methyl glucoside-derived ligand enabling high-yield asymmetric conjugate additions, offering cost-effective solutions for pharmaceutical intermediate manufacturing.
Patent CN106349130B reveals asymmetric Henry reaction for Florfenicol. Reduces waste and cost for veterinary antibiotic manufacturing supply chains.
Advanced synthesis of Boceprevir intermediate via patent CN103387510B. Offers cost reduction in pharmaceutical manufacturing and reliable supply chain solutions.
Novel patent CN117447427A details a cost-effective furosemide preparation method ensuring high purity and supply chain stability for global pharmaceutical procurement.